Lifeward (LFWD) Cash & Equivalents Growth (1y) (2015 - 2026)
Lifeward (LFWD) Cash & Equivalents Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.15% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 24.05% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -7.50% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 100.41% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -22.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 20.15% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 23.57% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -7.71% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 156.03% |
| 10 | Lifeward | 11.14 Mn | -263,371.13 | 1.34 Mn | 99.02% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.02% |
| Dec 31, 2025 | -67.85% |
| Sep 30, 2025 | -81.23% |
| Jun 30, 2025 | -66.29% |
| Mar 31, 2025 | -72.39% |
| Dec 31, 2024 | -75.98% |
| Sep 30, 2024 | -67.31% |
| Jun 30, 2024 | -74.00% |
| Mar 31, 2024 | -66.48% |
| Dec 31, 2023 | -58.64% |
| Sep 30, 2023 | -55.98% |
| Jun 30, 2023 | -26.14% |
| Mar 31, 2023 | -25.08% |
| Dec 31, 2022 | -23.14% |
| Sep 30, 2022 | -18.85% |
| Jun 30, 2022 | 22.67% |
| Mar 31, 2022 | 22.53% |
| Dec 31, 2021 | 334.09% |
| Sep 30, 2021 | 405.41% |
| Jun 30, 2021 | 356.74% |